http://archive.fast-edgar.com/20240423/AQL7M222Z222B2Z2222P22ZOI8A8ZQ222262
Filed on: April 23, 2024
http://archive.fast-edgar.com/20240423/AH22T22CF222Q2Z2222922YZP5SBY2Y26262
Filed on: April 23, 2024
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13A-16 OR 15D-16
OF THE SECURITIES EXCHANGE ACT OF 1934
For the month of April 2024
MOBILICOM LIMITED
Commission File Number 001-41427
(Translation of registrant’s name into English)
1 Rakefet Street
Shoham, Israel 6083705
(Address of principal executive offices)
Indicate by check mark... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
☐
Preliminary Proxy Statement
☐
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
☒
Definitive Proxy... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
100 F Street, N.E.
Washington, D.C. 20549
REPORT OF
INTERNATIONAL FINANCE CORPORATION
In respect of its
Issue of U.S.$15,000,000 4.84 per cent. Fixed Rate Notes due March 23, 2027
under its
Global Medium-Term Note Program
FILED PURSUANT TO RULE 3 OF REGULATION IFC
Dated: April 23, 2024
The following information regarding an issue of Issue of U.S.$ 15,000,000 4.84 per cent. Fixed Rate... (continue reading...)
More SEC Filings
View Older Stories-
Form 8-K CAMBRIDGE BANCORP For: Apr 23
-
Form DSTRBRPT International Finance
-
Form DEF 14A Cabaletta Bio, Inc. For: Jun 03
-
Form DSTRBRPT International Finance
-
Form 8-K Seres Therapeutics, Inc. For: Apr 19
-
Form 10-Q MANHATTAN BRIDGE CAPITAL For: Mar 31
-
Form 8-K ClearSign Technologies For: Apr 22
-
Form 8-K Theriva Biologics, Inc. For: Apr 23
-
Form 10-Q MBC FUNDING II CORP. For: Mar 31
-
Form 6-K Tiziana Life Sciences For: Apr 23
-
Form 8-K CAMBRIDGE BANCORP For: Apr 23
-
Form 8-K Option Care Health, Inc. For: Apr 23
-
Form 8-K RTX Corp For: Apr 23
-
Form 10-Q BANK OF HAWAII CORP For: Mar 31
-
Form 8-K PENTAIR plc For: Apr 23
-
Form 8-K RYDER SYSTEM INC For: Apr 23
-
Form 8-K MSCI Inc. For: Apr 23
-
Form 1-K Red Oak Capital Fund For: Dec 31
-
Form 8-K QUEST DIAGNOSTICS INC For: Apr 23
-
Form D Emma Grace Healing Hospi
-
Form 6-K GENETIC TECHNOLOGIES For: Apr 23
-
Form 8-K XEROX CORP For: Apr 23 Filed by: Xerox Holdings Corp
-
Form ARS UNIVERSAL HEALTH REALTY For: Dec 31
-
Form 8-K CARDINAL HEALTH INC For: Apr 23
-
Form 6-K GENETIC TECHNOLOGIES For: Apr 23
-
Form DEFA14A UNIVERSAL HEALTH REALTY
-
Form 8-K Aquaron Acquisition Corp For: Apr 19
-
Form 20-F ONECONNECT FINANCIAL For: Dec 31
-
Form D Palumni-SM-0404 Fund I,
-
Form 6-K GENETIC TECHNOLOGIES For: Apr 23
-
Form 6-K Ermenegildo Zegna N.V. For: Apr 23
-
Form 10-Q HERC HOLDINGS INC For: Mar 31
-
Form 1-K Future Cardia, Inc. For: Dec 31
-
Form 8-K HERC HOLDINGS INC For: Apr 23
-
Form DEF 14A UNIVERSAL HEALTH REALTY For: Jun 05
-
Form 8-K JETBLUE AIRWAYS CORP For: Apr 23
-
Form 6-K GENETIC TECHNOLOGIES For: Apr 23
-
Form 6-K Baozun Inc. For: Apr 23
-
Form D MU-0311 Fund II, a serie
-
Form 8-K Flutter Entertainment For: Apr 23
-
Form 20-F Yalla Group Ltd For: Dec 31
-
Form 10-Q GENERAL ELECTRIC CO For: Mar 31
-
Form SC TO-I/A CONX Corp. Filed by: CONX Corp.
-
Form 6-K SMITH & NEPHEW PLC For: Apr 23
-
Form 8-K GENERAL ELECTRIC CO For: Apr 23
-
Form 6-K NatWest Group plc For: Apr 23
-
Form S-1/A Loar Holdings Inc.
-
Form 10-K Fisker Inc./DE For: Dec 31
-
Form 8-K BANC OF CALIFORNIA, INC. For: Apr 23
-
Form 8-K TransUnion For: Apr 23